acute myeloid leukemia (AML) | Page 34 | Aplastic Anemia & MDS International Foundation Return to top.

acute myeloid leukemia (AML)

Jodi Mayfield, MD, MS

Mayfield, Jodi
Assistant Professor, Department of Pediatrics, Division of Pediatric Hematology & Oncology
University of New Mexico Comprehensive Cancer Center

Dr. Jodi Mayfield is an Assistant Professor of Pediatric Hematology/Oncology and Stem Cell research at the University of New Mexico. She received her MD from the University of New Mexico Health Sciences Center in 2008. She is currently a member of the American Society of Hematology and the Children's Oncology Group. Dr. Mayfield's areas of practice include Stem Cell transplantation, Acute Leukemias, and

Unmanipulated Haploidentical Hematopoietic Stem Cell Transplantation Achieved Outcomes Comparable With Matched Unrelated Donor Transplantation in Young Acquired Severe Aplastic Anemia

Author(s): 
Lu Y, Sun RJ, Zhao YL, Xiong M, Cao XY, Zhang JP, Wei ZJ, Zhou JR, Liu DY, Lu DP
Primary Author: 
Lu Y
Journal Title: 
Biol Blood Marrow Transplant
Original Publication Date: 
May 2018

Salvage haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is considered in patients with severe

Bone Marrow Disease(s): 

Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome

Author(s): 
Slade M, DiPersio J, Westervelt P, Vij R, Schroeder M, Romee R
Primary Author: 
Slade M
Journal Title: 
Biology of Blood and Marrow Transplantation
Original Publication Date: 
Nov 2017

Many hematologic malignancies are diseases of aging, and the use of hematopoietic cell transplant (HCT) is growing rapidly among older adults. Modern post-transplant

Share with addtoany.com.